In humans, S100B may induce plasticity effects in the brain, and an imaging study demonstrated a high S100B expression in human corpus callosum [72], so opening new perspectives for future studies investigating schizophrenia and other major neuropsychiatric disorders. Here, S100B is linked to schizophrenia.